JP2015508887A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508887A5 JP2015508887A5 JP2014555851A JP2014555851A JP2015508887A5 JP 2015508887 A5 JP2015508887 A5 JP 2015508887A5 JP 2014555851 A JP2014555851 A JP 2014555851A JP 2014555851 A JP2014555851 A JP 2014555851A JP 2015508887 A5 JP2015508887 A5 JP 2015508887A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- patient
- inflammasome
- level
- cns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261595254P | 2012-02-06 | 2012-02-06 | |
| US61/595,254 | 2012-02-06 | ||
| PCT/US2013/024941 WO2013119673A1 (en) | 2012-02-06 | 2013-02-06 | Innate immune proteins as biomarkers for cns injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015508887A JP2015508887A (ja) | 2015-03-23 |
| JP2015508887A5 true JP2015508887A5 (https=) | 2016-02-25 |
| JP6170071B2 JP6170071B2 (ja) | 2017-07-26 |
Family
ID=48947960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555851A Active JP6170071B2 (ja) | 2012-02-06 | 2013-02-06 | Ｃｎｓ損傷についてのバイオマーカーとしての自然免疫タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US20150185232A1 (https=) |
| EP (1) | EP2812697B1 (https=) |
| JP (1) | JP6170071B2 (https=) |
| CA (1) | CA2863417C (https=) |
| ES (1) | ES2630905T3 (https=) |
| WO (1) | WO2013119673A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| WO2021222263A2 (en) * | 2020-04-27 | 2021-11-04 | University Of Miami | Compositions and methods for treating inflammasome related diseases or conditions |
| CN106605146B (zh) * | 2014-04-08 | 2020-07-28 | 佛罗里达大学研究基金会有限公司 | 用于中枢神经系统的急性、亚急性和慢性创伤性损伤的蛋白质标志物 |
| RU2019123160A (ru) | 2016-12-29 | 2021-01-29 | Юниверсити Оф Майами | Способ модуляции активности инфламмасом и воспаления в легком |
| US11840565B2 (en) | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
| KR101910269B1 (ko) * | 2017-02-24 | 2018-10-19 | 성균관대학교산학협력단 | 인간 뇌 조직 유래 신경줄기세포의 고효율 분리 방법 |
| WO2019060516A1 (en) * | 2017-09-20 | 2019-03-28 | University Of Miami | METHOD FOR DETECTION OF INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS |
| WO2019199869A1 (en) * | 2018-04-10 | 2019-10-17 | Quanterix Corporation | Quantification of biomarkers present in physiological samples |
| SG11202013176VA (en) | 2018-07-03 | 2021-01-28 | Univ Miami | Compositions and methods for treating inflammasome related diseases or conditions |
| GB201815045D0 (en) | 2018-09-14 | 2018-10-31 | Univ Ulster | Bispecific antibody targeting IL-1R1 and NLPR3 |
| CN109406795A (zh) * | 2018-11-20 | 2019-03-01 | 昆明医科大学 | 一种轻型脑外伤的血清分子诊断标记物及应用 |
| US12601748B2 (en) | 2019-01-31 | 2026-04-14 | Universite De Geneve | Prospective markers in traumatic brain injury (TBI) |
| WO2021071934A1 (en) * | 2019-10-07 | 2021-04-15 | United States Government As Represented By The Department Of Veterans Affairs | Polymeric methylprednisolone conjugates and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004022156A2 (en) * | 2002-09-04 | 2004-03-18 | Washington University | Methods for treating central nervous system damage |
| US8685400B2 (en) * | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| WO2009100131A2 (en) * | 2008-02-04 | 2009-08-13 | Banyan Biomarkers, Inc. | Process to diagnose or treat brain injury |
| US8404752B2 (en) * | 2008-07-18 | 2013-03-26 | Oxygen Biotherapeutics, Inc. | Method of treating traumatic brain injury |
| US20120177632A1 (en) * | 2011-01-10 | 2012-07-12 | Shinohara Mari L | Methods of optimizing disease treatment |
-
2013
- 2013-02-06 EP EP13746979.7A patent/EP2812697B1/en active Active
- 2013-02-06 ES ES13746979.7T patent/ES2630905T3/es active Active
- 2013-02-06 WO PCT/US2013/024941 patent/WO2013119673A1/en not_active Ceased
- 2013-02-06 US US14/376,383 patent/US20150185232A1/en not_active Abandoned
- 2013-02-06 CA CA2863417A patent/CA2863417C/en active Active
- 2013-02-06 JP JP2014555851A patent/JP6170071B2/ja active Active
-
2016
- 2016-07-20 US US15/214,868 patent/US20170003303A1/en not_active Abandoned
-
2020
- 2020-08-06 US US16/986,904 patent/US20200363432A1/en not_active Abandoned
-
2023
- 2023-07-05 US US18/347,108 patent/US12560618B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508887A5 (https=) | ||
| Green et al. | Non-genetic and genetic risk factors for adult cerebral venous thrombosis | |
| Aly et al. | Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome | |
| Eijsvogel et al. | Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial | |
| Wu et al. | Neurosyphilis: insights into its pathogenesis, susceptibility, diagnosis, treatment, and prevention | |
| Wilking et al. | Central nervous system manifestations in pediatric patients with influenza A H1N1 infection during the 2009 pandemic | |
| CN106461645A (zh) | 外伤性脑损伤和神经退行性生物标记物、方法和系统 | |
| JP2026016513A (ja) | アルツハイマー病を判定するためのタンパク質マーカー | |
| Tüzün et al. | Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients | |
| WO2019117270A1 (ja) | 頭頸部がんの検出を補助する方法 | |
| KR20170062478A (ko) | 우울증 치료약의 선택지를 예측하는 방법 | |
| JP2017519522A (ja) | 新規分子バイオマーカーを使用して慢性閉塞性肺疾患（ｃｏｐｄ）を診断する方法 | |
| JP2017519521A (ja) | 新規分子バイオマーカーを使用して慢性閉塞性肺疾患（ｃｏｐｄ）を診断する方法 | |
| US10067142B2 (en) | Method for diagnosing, treating, or preventing mood disorder | |
| Arslan et al. | Importance of endothelial dysfunction biomarkers in patients with Crimean‐Congo hemorrhagic fever | |
| JP2018504909A5 (https=) | ||
| Wei et al. | The first human infection with severe fever with thrombocytopenia syndrome virus in Shaanxi Province, China | |
| Barratt‐Due et al. | Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients | |
| Kumar et al. | Enhanced expression of Toll‐like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis | |
| Vittorakis et al. | Circulating conventional and plasmacytoid dendritic cell subsets display distinct kinetics during in vivo repeated allergen skin challenges in atopic subjects | |
| Yang et al. | Increased phosphorylated tau (pTau-181) is associated with neurological post-acute sequelae of coronavirus disease in essential workers: a prospective cohort study before and after COVID-19 onset | |
| JP2017513021A5 (https=) | ||
| JP2021534385A5 (https=) | ||
| JP2017521092A (ja) | アルツハイマー病の診断検査及び治療／予防 | |
| Mauleti et al. | EFFECT OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS ON LENGTH OF HOSPITAL STAY FOR ADULT DENGUE PATIENTS: A RETROSPECTIVE STUDY AT A TERTIARY CARE HOSPITAL, JAKARTA, INDONESIA |